Programs currently tracked for this institution in the public Translational Deal Radar dataset.
Anti-CD22 CAR NK Cells is flagged as a low confidence because it has an active early-phase oncology cell-therapy trial at Allife Medical Science and Technology Co., Ltd., with a unlinked patent signal linked through public patent-search heuristics. Manual review is still required.
Early Phase1 · Unknown
View assetanti-Mesothelin Car NK Cells is flagged as a low confidence because it has an active early-phase oncology cell-therapy trial at Allife Medical Science and Technology Co., Ltd., with a unlinked patent signal linked through public patent-search heuristics. Manual review is still required.
Early Phase1 · Unknown
View asset